Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis.
Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis.
复制标题
DOI:
10.1371/journal.pbio.3001746
复制
发表时间:
2023-05
期刊:
影响因子:
9.8
通讯作者:
Choi, Kyunghee
中科院分区:
文献类型:
--
作者:
Barisas, Derek A. G.;Ul Kabir, Ashraf;Wu, Jun;Krchma, Karen;Kim, Minseo;Subramanian, Madhav;Zinselmeyer, Bernd H. H.;Stewart, Colin L. L.;Choi, Kyunghee
Extramedullary hematopoiesis (EMH) expands hematopoietic capacity outside of the bone marrow in response to inflammatory conditions, including infections and cancer. Because of its inducible nature, EMH offers a unique opportunity to study the interaction between hematopoietic stem and progenitor cells (HSPCs) and their niche. In cancer patients, the spleen frequently serves as an EMH organ and provides myeloid cells that may worsen pathology. Here, we examined the relationship between HSPCs and their splenic niche in EMH in a mouse breast cancer model. We identify tumor produced IL-1α and leukemia inhibitory factor (LIF) acting on splenic HSPCs and splenic niche cells, respectively. IL-1α induced TNFα expression in splenic HSPCs, which then activated splenic niche activity, while LIF induced proliferation of splenic niche cells. IL-1α and LIF display cooperative effects in activating EMH and are both up-regulated in some human cancers. Together, these data expand avenues for developing niche-directed therapies and further exploring EMH accompanying inflammatory pathologies like cancer. This study shows that tumor-produced IL-1α and LIF promote extramedullary hematopoiesis. LIF directly expands splenic niche cells while IL-1α induces TNFα production in hematopoietic stem and progenitor cells to activate splenic niche cells; both expand myeloid-biased splenic hematopoiesis.
登录
查看更多内容
影响因子:
12.8
作者:
Fan N;Lavu S;Hanson CA;Tefferi A
通讯作者:
Tefferi A
DOI:
10.1073/pnas.1113744109
发表时间:
2012-02-14
影响因子:
11.1
作者:
Cortez-Retamozo, Virna;Etzrodt, Martin;Pittet, Mikael J.
通讯作者:
Pittet, Mikael J.
DOI:
10.1093/rheumatology/keq031
发表时间:
2010-07
期刊:
Rheumatology (Oxford, England)
影响因子:
--
作者:
Horiuchi T;Mitoma H;Harashima S;Tsukamoto H;Shimoda T
通讯作者:
Shimoda T
影响因子:
5.3
作者:
GUY, CT;CARDIFF, RD;MULLER, WJ
通讯作者:
MULLER, WJ
影响因子:
3.3
作者:
Bao Y;Liu Z;Guo M;Li B;Sun X;Wang L
通讯作者:
Wang L